等待开盘 07-10 09:30:00 美东时间
+0.830
+1.68%
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从66.5美元升至72美元;HC Wainwright & Co.:维持Vera Therapeutics"买入"评级,目标价从110美元升至125美元
07-09 12:35
今日重点评级关注:Canaccord Genuity:维持AtaiBeckley"买入"评级,目标价从15美元升至17美元;Truist Securities:维持NUVATION BIO"买入"评级,目标价从12美元升至13美元
07-08 15:31
Truist Securities analyst Keith Hughes downgrades Amrize (NYSE:AMRZ) from Buy to Hold and lowers the price target from $65 to $48.
07-07 18:36
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon June 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Baldwin Insurance Group, Diamondback Energy and Visteon, on Monday. HIGHLIGHTS * Baldwin
06-22 15:47
Amrize Ltd ( ($AMRZ) ) has issued an update. Amrize has begun a major moderniza...
06-19 23:08
今日重点评级关注:TD Cowen:维持Strive"买入"评级,目标价从28美元升至30美元;蒙特利尔银行:维持KinderCare Learning"跑赢大市"评级,目标价从4美元升至6美元
05-19 10:55
Stephens & Co. analyst Trey Grooms reiterates Amrize (NYSE:AMRZ) with a Overweight and maintains $65 price target.
05-18 21:19
华盛资讯5月8日讯,Amrize Ltd公布2026财年Q1业绩,公司Q1营收21.78亿美元,同比增长4.7%,归母净利润亏损1.16亿美元,同比亏损扩大33.3%。
05-08 06:39
Amrize Ltd ( ($AMRZ) ) has issued an announcement. Amrize Ltd has launched a $1...
05-05 13:32
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40